Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a double-blind, randomized phase III prevention trial (parallel assignment) evaluating CP101 (oral application) vs placebo in adult patients with Clostridioides difficile infection (CDI) (recurrent)
Sustained Clinical Cure Through Week 8
No published results were found as of June 2026
…